TY  - GEN
AU  - Hanto,Douglas W
AU  - Chudzinski,Robyn
TI  - What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
SN  - 1534-6080
PY  - 2009///0210
KW  - Calcineurin Inhibitors
KW  - Cyclosporine
KW  - administration & dosage
KW  - Drug Therapy, Combination
KW  - Glomerular Filtration Rate
KW  - drug effects
KW  - Graft Rejection
KW  - mortality
KW  - Graft Survival
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kidney Transplantation
KW  - adverse effects
KW  - Randomized Controlled Trials as Topic
KW  - Research Design
KW  - Sirolimus
KW  - Tacrolimus
KW  - Time Factors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/TP.0b013e318192790f
ER  -